These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33270350)

  • 1. What is the role of admission HbA1c in managing COVID-19 patients?
    Sathish T; Cao Y
    J Diabetes; 2021 Mar; 13(3):273-275. PubMed ID: 33270350
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 infection-related diabetes mellitus.
    Beliard K; Wilkes M; Yau M; Aluf A; Rapaport R
    J Diabetes; 2021 Jun; 13(6):523-524. PubMed ID: 33660918
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher values of fasting blood glucose and glycated hemoglobin are not associated with mortality in Covid-19 Mexican patients.
    Gastélum-Cano JM; Islas-Osuna MA; Arízaga-Berber JA
    Prim Care Diabetes; 2021 Feb; 15(1):1-3. PubMed ID: 33221271
    [No Abstract]   [Full Text] [Related]  

  • 4. Is prediabetes a risk factor for severe COVID-19?
    Sathish T; Chandrasekaran ND
    J Diabetes; 2021 Jun; 13(6):521-522. PubMed ID: 33559395
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycosylated hemoglobin and glycosylated proteins for metabolic control of diabetes mellitus].
    Schnedl WJ; Leitner G; Lipp RW
    Wien Med Wochenschr; 1997; 147(15):359-61. PubMed ID: 9432808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Blood Glucose and Hemoglobin A1C in COVID-19: a Preliminary Summarization.
    Sookaromdee P; Wiwanitkit V
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902219
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).
    Sonmez A; Demirci I; Haymana C; Tasci I; Dagdelen S; Salman S; Ata N; Sahin I; Emral R; Cakal E; Atmaca A; Sahin M; Celik O; Demir T; Ertugrul D; Unluturk U; Caglayan M; Satman I
    J Diabetes; 2021 Jul; 13(7):585-595. PubMed ID: 33655669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between glycated haemoglobin and glucose testing for diabetes mellitus screening.
    Agarwal N; Joshi S; Deshpande VK; Biswas DA
    Indian J Med Sci; 2013; 67(7-8):149-54. PubMed ID: 24469558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved individual and population-level HbA1c estimation using CGM data and patient characteristics.
    Grossman J; Ward A; Crandell JL; Prahalad P; Maahs DM; Scheinker D
    J Diabetes Complications; 2021 Aug; 35(8):107950. PubMed ID: 34127370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing.
    Sattar N; Preiss D
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):560-2. PubMed ID: 27039357
    [No Abstract]   [Full Text] [Related]  

  • 11. Can we become victims of our own success?
    Buse JB
    Diabetes Care; 2009 Nov; 32(11):2140-1. PubMed ID: 19875611
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID-19: A Retrospective Study.
    Yuan S; Li H; Chen C; Wang F; Wang DW
    J Cell Mol Med; 2021 Apr; 25(7):3484-3497. PubMed ID: 33694276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
    Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycosylated hemoglobin and diabetes mellitus].
    Compagnucci P; Cartechini MG
    Recenti Prog Med; 1986 May; 77(5):257-66. PubMed ID: 3526463
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.
    Karayiannides S; Djupsjö C; Kuhl J; Hofman-Bang C; Norhammar A; Holzmann MJ; Lundman P
    Cardiovasc Diabetol; 2021 Jun; 20(1):122. PubMed ID: 34126971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A1C: recommendations, debates, and questions.
    Bloomgarden ZT
    Diabetes Care; 2009 Dec; 32(12):e141-7. PubMed ID: 19940210
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 pandemic: Can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?
    Nachtergaele C; Vicaut E; Pinto S; Tatulashvili S; Bihan H; Sal M; Berkane N; Allard L; Baudry C; Carbillon L; Cosson E
    Diabetes Res Clin Pract; 2021 Feb; 172():108640. PubMed ID: 33359083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
    Li H; Tian S; Chen T; Cui Z; Shi N; Zhong X; Qiu K; Zhang J; Zeng T; Chen L; Zheng J
    Diabetes Obes Metab; 2020 Oct; 22(10):1897-1906. PubMed ID: 32469464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to Chantelau and Rech.
    Tahara Y; Shima K
    Diabetes Care; 1994 Apr; 17(4):345. PubMed ID: 8026293
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemoglobin A(1c)--a new tool in diagnosing diabetes].
    Aulinger B; Rau T
    MMW Fortschr Med; 2011 May; 153(21):35-8. PubMed ID: 21736063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.